+ Translate

Reinfection of the second liver allograft in patients undergoing retransplantation for severe recurrent hepatitis C viral infection

, : Reinfection of the second liver allograft in patients undergoing retransplantation for severe recurrent hepatitis C viral infection. Hepatology 32(4 Pt 2): 257A, October

(PDF 0-2 workdays service)

Accession: 035638843

Submit PDF Full Text: Here

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:

Related references

Fiel, M.I.; Schiano, T.D.; Min, A.D.; Kim Schluger, L.; Sheiner, P.A.; Sigel, S.H.; Bodenheimer, H.C.; Thung, S.N., 1999: Histopathologic and clinical features of patients undergoing retransplantation for recurrent hepatitis C viral infection. Hepatology 30(4 PART 2): 247A, Oct

Neff, G.W.; O'Brien, C.B.; Nery, J.; Shire, N.J.; Nishida, S.; delaGarza, J.; Montalbano, M.; Safdar, K.; Ruiz, P.; Rideman, E.; Gascon, J.A.; Tzakis, A.G.; Madariaga, J.; Rudich, S.M., 2004: Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection. Hepatitis C virus (HCV) is becoming the most common indication for liver retransplantation (ReLTx). This study was a retrospective review of the medical records of liver transplant patients at our institution to determine factors that would identi...

Rosen, H.R.; Martin, P., 1999: Hepatitis C infection in patients undergoing liver retransplantation. There is concern that repeat orthotopic liver transplantation in patients with hepatitis C virus (HCV) infection may be associated with poor long-term survival. The specific aims of the current analysis were to determine (1) the prevalence of HCV...

Bozorgzadeh, A.; Jain, A.B.; Daller, J.; Ryan, C.; Sundrum, U.; Lansing, K.; Kaufman, D.; Ornt, D.; Zand, M.; Betts, R.; Orloff, M., 2003: Impact of hepatitis C viral infection in primary cadaveric liver allograft v/s primarily living liver allograft in 100 consecutive liver transplant patients?. Back Ground: With increasing demand for liver transplantation (LTx) and relatively static supply of cadaveric organs, living donor liver transplantation (LLTx) has emerged as an accepted therapeutic modality. Currently, there has been concern that...

Kita, Y.; Klintmalm, Göran.; Kobayashi, S.; Yanaga, K., 2007: Retransplantation for de novo hepatocellular carcinoma in a liver allograft with recurrent hepatitis B cirrhosis 14 years after primary liver transplantation. Mesalazine is a first-line drug in pediatric inflammatory bowel disease, and is effective as primary treatment and maintenance therapy. It's usually well tolerated, but various side effects have been described. A 15-year-old female with ulcer...

Ishitani, M.; McGory, R.; Dickson, R.; Caldwell, S.; Bickston, S.; McCullough, C.; Pruett, T., 1996: Successful retransplantation for recurrent posttransplant hepatitis B virus infection in the primary allograft. Transplantation Proceedings 28(3): 1714-1716

Berenguer, M.; Prieto, Mín.; Palau, A.; Rayón, Jé.M.; Carrasco, D.; Juan, F.San.; López-Labrador, F-Xavier.; Moreno, R.; Mir, Jé.; Berenguer, Jín., 2003: Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis. An increase in the number of hepatitis C virus (HCV)-infected transplant recipients at need for repeated liver transplantation is anticipated. To date, there is a certain reluctance to accept these patients because of an increased organ shortage,...

Ishitani, M.; McGory, R.; Dickson, R.; Caldwell, S.; Bickston, S.; McCullough, C.; Pruett, T.; Terrault, N.; Roberts, J.; Ascher, N.; Wright, T.; Lake, J., 1997: Retransplantation of patients with severe posttransplant hepatitis B in the first allograft. Background. The outcome of orthotopic liver transplantation (OLTX) in patients retransplanted for severe hepatitis B virus (HBV) in the first allograft has been poor due to high rates of HBV reinfection and even more aggressive disease in the seco...

Cirocco, R.; Fragulidis, G.P.; Weppler, D.; Zucker, K.; Markou, M.; Zervos, X.A.; Viciana, A.; Esquinazi, V.; Nery, J.R.; Reddy, K.R.; Schiff, E.; Miller, J.; Tzakis, A.G., 1997: Recurrent hepatitis C infection following orthotopic liver transplantation is predicted by posttransplant serum and hepatic allograft viral titers. Transplantation Proceedings 29(7): 2839-2840

Casavilla, F.A.; Lee, R.; Lim, J.; Kramer, D.; Irish, W.; Rakela, J.; Fung, J.J., 1995: Outcome of liver retransplantation for recurrent hepatitis C infection. Hepatology 22(4 PART 2): 153A